Categories: News

Vireo Growth Inc. to Release Second Quarter 2024 Results on August 6, 2024

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

MINNEAPOLIS, July 23, 2024 (GLOBE NEWSWIRE) — Vireo Growth Inc. (formerly Goodness Growth Holdings, Inc.) (“Vireo” or the “Company”) (CSE: VREO; OTCQX: VREOF), a cannabis company committed to providing safe access, quality products and great value to its customers, today announced that it will release its financial results for its second quarter ended June 30, 2024 on Tuesday, August 6, 2024 after the market closes.

Vireo management will host a conference call with the investment community that day, Tuesday, August 6, 2024 at 4:30 p.m. ET (3:30 p.m. CT) to discuss its results. Interested parties may attend the conference call by dialing 1-800-715-9871 (Toll-Free) (US and Canada) or 1-646-307-1963 (Toll) (International) and referencing conference ID number 3718174.

A live audio webcast of this event will also be available in the Events & Presentations section of the Company’s Investor Relations website and via the following link: https://events.q4inc.com/attendee/837840088.

About Vireo Growth Inc.

Vireo was founded as a pioneer in medical cannabis in 2014 and we are fueled by an entrepreneurial drive that sustains our ongoing commitment to serve and delight our key stakeholders, most notably our customers, our employees, our shareholders, our industry collaborators, and the communities in which we live and operate. We work every day to get better and our team prioritizes 1) empowering and supporting strong local market leaders and 2) strategic, prudent capital and human resource allocation. For more information, please visit www.vireogrowth.com.

Contact Information

Investor Inquiries:
Sam Gibbons
Investor Relations
investor@vireogrowth.com
(612) 314-8995

Media Inquiries:
Amanda Hutcheson
Senior Manager, Communications
amandahutcheson@vireogrowth.com  
(919) 815-1476

Staff

Recent Posts

Alcon Publishes Agenda for 2025 Annual General Meeting

Alcon welcomes its shareholders to its third in-person AGM Alcon Board of Directors proposes to…

47 minutes ago

Hologic to Announce Financial Results for the Second Quarter of Fiscal 2025 on Thursday, May 1, 2025

MARLBOROUGH, Mass.--(BUSINESS WIRE)--$HOLX #earnings--Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release…

51 minutes ago

BIZCLIK MEDIA PUBLISHES APRIL EDITION OF HEALTHCARE DIGITAL

The April edition of Healthcare Digital features exclusive insights from leaders at Abzena, Arcutis Biotherapeutics, Spotfire, S&P…

56 minutes ago

TALON selects Litchfield Underwriters to provide Comprehensive Stop-Loss Coverage for Transformative Equitable Healthcare Pricing Network

PORTSMOUTH, N.H., April 4, 2025 /PRNewswire/ -- Litchfield Underwriters, industry leaders in providing superior self-funded…

56 minutes ago

Google Cloud and Ai2 Commit $20M to Advance AI-Powered Research for the Cancer AI Alliance

Google Cloud to provide advanced and secure technology, while Ai2 to lead AI training and…

57 minutes ago

Cumulus Neuroscience Presents Data at AD/PD™ 2025 Annual Meeting

Validation data presented at the 2025 Alzheimer's & Parkinson's Diseases (AD/PD) Conference confirms two novel…

57 minutes ago